Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Press Release

Users of MOSAIQ Oncology Information System Among First Oncologists to Achieve Meaningful Use

PR Newswire

ATLANTA, May 10, 2012 /PRNewswire/ -- Users of Elekta's MOSAIQ® Oncology Information System (OIS) – the first comprehensive, oncology-specific EMR certified for meaningful use under the federal government's American Recovery and Reinvestment Act – have begun completing the "attestation" process to prove meaningful use. Fulfilling attestation requirements qualifies users of MOSAIQ and other systems to receive payments from the Centers for Medicare & Medicaid Services (CMS) of up to $44,000 over five years under Medicare rules.

Two Elekta customer sites became the first MOSAIQ users to attest in 2012 by proving meaningful use over a 90-day period. During that period, the centers were required to meet 20 patient-focused measures using MOSAIQ to record and manage patient records electronically.

Four medical oncologists at Cancer Specialists of Oklahoma (Oklahoma City, Okla.) submitted their attestations on April 5, qualifying each to receive $18,000 in incentive funds in 2012. Additional payments up to a total of $44,000 per physician are receivable until 2016 by continuing to meet meaningful use requirements under Medicare rules.

"Our physicians and staff are very pleased and proud at having met the challenging attestation requirements, and that they are in the first group of MOSAIQ users to do so," says Margo Gonzales, Business Office Administrator at Cancer Specialists of Oklahoma.

A radiation oncologist from Tuality / Oregon Health & Science University (OHSU) Cancer Center LLC (Hillsboro, Ore.), submitted her attestation on April 12, according to Tina Dickerson, R.T.(R)(T), Chief Therapist/Manager at Tuality / OHSU Cancer Center, which is affiliated with the OHSU Knight Cancer Institute.

"Completing attestation for Stage 1 meaningful use is an accomplishment – I'm glad we were able to get it done this quickly," she says. "The Elekta service group was on hand to help answer questions. The experience has made us more confident to achieve the next attestation for Stage 2 meaningful use."

In 2012, centers are attesting for the first of three stages of meaningful use. Stage 2 criteria are in final review and are expected to be released in June 2012. These criteria will build on those from Stage 1, and MOSAIQ will be certified for all future stages.

In addition to providing a certified EMR, Elekta offers custom programs through its STRATEGIQ™ consultative services to help clients prepare to demonstrate meaningful use.

"We're pleased to see the hard work by our customers on meaningful use is finally paying off," says Todd Powell, Executive Vice President, Elekta Software. "MOSAIQ provides an important tool to make that possible, but the real credit for this achievement goes to the physicians, administrators and the rest of their teams who successfully took on this challenge."

For information on how MOSAIQ has been modified to address meaningful use criteria, visit www.elekta.com/HITECH.

# # #

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

 

SOURCE Elekta

Latest News
Top News
Engage

Corporate

Help & Support

News Links

copyright © 2014 digitaljournal.com   |   powered by dell servers